In vitro experiments have indicated that EGCG treatment led to the transcriptional inhibition of IFN-γ mediated upregulation of PD-L1 and PD-L2 across all tested melanoma cell lines including 1205Lu, A375, and HS294T [245]. The gene discussed is CD274; the disease is melanoma.